 |
|
| Scheduled U.S. IPOs - Week of 03/17/2014 |
A10 Networks (ATEN) - San Jose, CA
Deal Size: $175 mil Price Range: $13.00 - $15.00 Shares Filed: 12,500,000
Lead Underwriter: Morgan Stanley
Provides software-based appliances that optimize data center performance.
|
Akebia Therapeutics (AKBA) - Cambridge, MA
Deal Size: $76 mil Price Range: $14.00 - $17.00 Shares Filed: 4,900,000
Lead Underwriter: Morgan Stanley
Biotech developing a breakthrough anemia treatment with a once-daily oral dose.
|
Amber Road (AMBR) - East Rutherford, NJ
Deal Size: $75 mil Price Range: $10.50 - $12.50 Shares Filed: 6,522,000
Lead Underwriter: Stifel
Provides cloud-based global trade management software.
|
Borderfree (BRDR) - New York , NY
Deal Size: $75 mil Price Range: $14.00 - $16.00 Shares Filed: 5,000,000
Lead Underwriter: Credit Suisse
Provides a software platform to support international e-commerce for US retailers.
|
Globoforce (THNX) - Dublin, Ireland
Deal Size: $75 mil Price Range: $16.00 - $18.00 Shares Filed: 4,411,766
Lead Underwriter: J.P. Morgan
Provides cloud-based social recognition software solutions to enterprises.
|
MediWound (MDWD) - Yavne, Israel
Deal Size: $75 mil Price Range: $14.00 - $16.00 Shares Filed: 5,000,000
Lead Underwriter: Credit Suisse
Developing treatments for severe burns and other hard-to-heal wounds.
|
Paylocity (PCTY) - Arlington Heights, IL
Deal Size: $100 mil Price Range: $14.00 - $16.00 Shares Filed: 6,670,000
Lead Underwriter: Deutsche Bank
Provides cloud-based payroll and human capital management software.
|
Q2 Holdings (QTWO) - Austin, TX
Deal Size: $93 mil Price Range: $11.00 - $13.00 Shares Filed: 7,760,870
Lead Underwriter: J.P. Morgan
Provides an online banking SaaS platform to community banks.
|
Versartis (VSAR) - Redwood City, CA
Deal Size: $81 mil Price Range: $16.00 - $19.00 Shares Filed: 4,600,000
Lead Underwriter: Morgan Stanley
Biotech developing long-acting treatments for growth hormone deficiency. |
No comments:
Post a Comment